Lisa Anderson, MD
Emergency Medical Services · Madison, MSNPI 1699703389
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $277 of the $330 with a category attached, or 84.1%. 9 manufacturers reported payments, led by AbbVie at 26.1% of the total. Reporting peaked in 2019 at $116 and has fallen 84.4% since, to $18 in 2025.
Across 19 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$86
- Genentech USA, Inc.$84
- Welch Allyn$53
- AstraZeneca$37
- Optinose US, Inc.$23
- Exact Sciences$13
- plus $34 from 3 others
What the payments were for
- Food & beverage$27784%
- Other$5316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 6 | $86 |
| Genentech USA, Inc. | 5 | $84 |
| Welch Allyn | 1 | $53 |
| AstraZeneca | 2 | $37 |
| Optinose US, Inc. | 1 | $23 |
| Exact Sciences | 1 | $13 |
| Almirall LLC | 1 | $12 |
| Melinta Therapeutics, LLC | 1 | $11 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$330 in reported general payments places this provider in the 70th percentile of 25 emergency medical services providers in Mississippi.
See all emergency medical services providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 76 | $2,171 |
| Doxycycline Hyclate | 117 | $932 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $883 |
| Cefdinir | 17 | $555 |
| Oseltamivir Phosphate | 16 | $393 |
| Azithromycin | 72 | $364 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $270 |
| Losartan Potassium | 28 | $243 |
| Levothyroxine Sodium | 30 | $230 |
| Amlodipine Besylate | 31 | $219 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $204 |
| Pravastatin Sodium | 11 | $177 |
| Atorvastatin Calcium | 27 | $161 |
| Ondansetron OdtOndansetron | 17 | $137 |
| Rosuvastatin Calcium | 16 | $134 |
Paid to pharmacies, not to this prescriber.
Other emergency medical services in Madison
- Max KeelingJackson$10K
- Philip LevinGulfport$748
- John BrooksJackson$708
- Bobbie WestJackson$701
- Chester ShermerJackson$441
- Amy DavisCorinth$378
- Eric ZoogJackson$364
- Greg TavaiHattiesburg$291
- David JohnsonYazoo City$259
- Melissa RobertsHattiesburg$181
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.